Celldex Therapeutics, Inc. Gain (Loss) Related to Litigation Settlement
Celldex Therapeutics, Inc. (CLDX) reported Gain (Loss) Related to Litigation Settlement of -$12.50 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2026-02-25
- Celldex Therapeutics, Inc. gain (loss) related to litigation settlement for the quarter ending 2022-12-31 was $0.00.
- Celldex Therapeutics, Inc. gain (loss) related to litigation settlement for the quarter ending 2022-09-30 was $0.00.
- Celldex Therapeutics, Inc. gain (loss) related to litigation settlement for the quarter ending 2022-06-30 was -$15.00M.
- Celldex Therapeutics, Inc. gain (loss) related to litigation settlement for fiscal 2023 was -$12.50M.
- Celldex Therapeutics, Inc. gain (loss) related to litigation settlement for fiscal 2022 was -$15.00M.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$12.50M 10-K · filed 2026-02-25 | |||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | -$15.00M derived: sum of 3 quarters · filed 2025-02-27 | -$15.00M 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$15.00M derived: sum of 2 quarters · filed 2023-11-02 | -$15.00M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | -$15.00M 10-Q · filed 2023-08-08 | -$15.00M 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |